PPT-RCR National Audit of Muscle Invasive Bladder Cancer (MIBC) – Initial Results

Dr Sarah Treece Peterborough City Hospital North West Anglia NHS Foundation trust Background NG2 It is stated that there is considerable variation across the NHS in the diagnosis and management of bladder cancer and the provision of care to people who have it. Bladder cancer. Etiology, classification, and diversity. David M. Berman, MD, PhD. Pathology and Molecular . Medicine. Queen’s Cancer Research Institute. bermand@queensu.ca. bermanlab.org. Objectives. Bladder Carcinomas. Incidence. Risk . factors. Staging. Histopathology. Papilloma. Transitional Cell Carcinoma. Nontransitional. Cell Carcinoma. Adenocarcinoma. Squamous. cell carcinoma. Undifferentiated carcinomas. TUMORS. D. Diar H. Bajalan. NEOPLASM OF BLADDER. 95 % of primary bladder tumours originate in the . epithelium. ;. The remainder arise from . connective tissue (. angioma. , . myoma. , . fibroma. and sarcoma) .. University Hospitals. Portage Medical Center. 2015 Bladder Cancer. Portage County has one of the highest annual incidence rates of bladder cancer in the state of Ohio. . According . to the surveillance epidemiology and end result [SEER] from 2007 through 2011 Portage County has an incidence rate of 23.6-26.0/100,000, while the national and Ohio State rates are at 20.6-22.1/100,000. . Diagnosis and Treatment. Albert McBride, MD, FICS. Epidemiology. Incidence . 74,690 new cases in 2014:. Men 56,390. Women 18,300. Mortality 15,580 deaths in 2014. Men 11,170. Women 4,410. 2014. 71,830 new cases of . How did I know?. What did I do?. How am I now?. Profile picture. Profile picture. Bladder Cancer . in Numbers. 16,870 will die in 2017. 79,030 diagnosed in 2017. 600K living with bladder cancer . most common cancer . Albert McBride, MD, FICS. Epidemiology. Incidence . 74,690 new cases in 2014:. Men 56,390. Women 18,300. Mortality 15,580 deaths in 2014. Men 11,170. Women 4,410. 2014. 71,830 new cases of . colo. -rectal cancer. DEPARTMENT OF UROLOGY, . SCHOOL OF MEDICINE, . BAHÇEŞEHİR UNIVERSITY. Bladder Cancer. (TCC). The second most common cancer of the genitourinary system. The male-female . . ratio. . is 2.7. /. 1. An audit of dose-fractionation schedules and timeliness of treatment. Dr L Dixon and Dr J Wadsley. Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK.. Background. Chemo-radiotherapy is a radical treatment option for patients with oesophageal cancer. . 1 Summary cancer type worldwide and is one of the most challenging and expensive cancers to diagnose and treat. Its diagnosis relies on cystoscopy, an invasive and expensive procedure that might n Mr Niall Gilliland. Miss Helena Burden. Miss Kate Warren. High risk non muscle invasive bladder cancer (NMIBC). SWAG guidelines. NICE Guidelines. Introduction. Retrospective. 233 patients. Single centre. Urologic Oncologist. Colorado Urology. Bladder Cancer Support Group . Inaugural Meeting. Why a Support Group?. Brings people with . similar experience together. Creates a . sense of belonging. Reduces feelings of isolation. Lori Wood, MD, MSc, FRCPC. Medical Oncologist, Queen Elizabeth II Health Sciences Centre. Professor of Medicine, Dalhousie University. Halifax, NS. Canada. Nepal. November 2017 . Objectives. Review basic epidemiology, staging, pathology. Dr. Vicente Marco. Department of Pathology. Hospital . Quiron. Barcelona. Spain. Second Opinion in Breast Pathology. Usually requested when a patient is referred from another institution for treatment.